UBS Maintains Neutral on Exelixis, Raises Price Target to $52
Exelixis, Inc.
Exelixis, Inc. EXEL | 0.00 |
UBS analyst Ashwani Verma maintains Exelixis (NASDAQ:
EXEL) with a Neutral and raises the price target from $43 to $52.
UBS Maintains Neutral on Exelixis, Raises Price Target to $52
Exelixis, Inc. EXEL | 0.00 |